Insights

All Categories

27 February 2013

OneVentures

Who’s disrupting your industry? Meet 10 start-ups eager to eat the big boys’ lunch


27 November 2012

OneVentures

Hatchtech publish data on Head Lice treatment safety study and mechanism of action


30 October 2012

OneVentures

Vaxxas recognised as Janssen Ausbiotech Emergeing Company of the Year 2012


25 October 2012

OneVentures

Novel Pediculicide Clears Most Head Lice With 1 Application


25 October 2012

OneVentures

Smart Sparrow a winner at Tech23


23 October 2012

OneVentures

Smart Sparrow a winner at Tech23 2012


08 October 2012

OneVentures

Vaxxas Appoints David Hoey as Company’s First CEO


08 October 2012

OneVentures

Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation


03 September 2012

OneVentures

Hatchtech announce successful End-of-Phase 2 for head lice product DeOvo™


08 August 2012

Virtual patient gets funding injection


08 August 2012

Garrett acts out NBN potential


15 July 2012

Digital tools can reshape our methods


17 April 2012

Best Venture Capital Investment at the 2012 Vaccine Industry Excellence Awards


09 February 2012

Vaxxas featured in BRW Top 10 start ups to watch


08 December 2011

Vaxxas wins Australian Innovation Challenge Awards


26 October 2010

Hatchtech raises $6.3m for DeOvo™ Head Lice Phase 2b Clinical Trial


20 September 2010

Vaxxas wins Australian Research Council Eureka Prize


09 April 2010

Feds seek more funds for innovation program


30 March 2010

Former i.lab CEO joins OneVentures investment team


29 March 2010

New venture capital fund with $40m to spend


29 March 2010

New venture capital fund launches for tech companies with revenue under $5 million


23 March 2010

$40m in venture capital for tech


21 June 2006

Hatchtech wins prize for best Victorian technology commercialisation from all industries


21 June 2006

Hatchtech wins Commercialisation Expo 2006 Prize for Best Australian Life Sciences Company